Advertisement
Screener

Q Therapeutics, Inc. Forms 3, 4 and 5: Other

Q Therapeutics, Inc. Forms 3, 4 and 5: Other

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2012-06-25: Reporting owner BORST STEVEN JOHN; Form 5; Security Warramts to Purchase Common Stock; Transaction G Bona fide gift.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2012-06-25BORST STEVEN JOHN
Officer (Chief Financial Officer)
5Warramts to Purchase Common Stock
Derivative · Indirect · (m)
G Bona fide gift+10,185
1,084,672 owned after
$2.002013-08-13